- Home
- GMS vs PCVX Comparison
GMS vs PCVX Comparison
Compare GMS & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMS
- PCVX
- Stock Information
- Founded
- GMS 1971
- PCVX 2013
- Country
- GMS United States
- PCVX United States
- Employees
- GMS 7113
- PCVX N/A
- Industry
- GMS
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- GMS
- PCVX Health Care
- Exchange
- GMS Nasdaq
- PCVX Nasdaq
- Market Cap
- GMS 4.2B
- PCVX 4.0B
- IPO Year
- GMS 2016
- PCVX 2020
- Fundamental
- Price
- GMS $109.96
- PCVX $32.34
- Analyst Decision
- GMS Hold
- PCVX Strong Buy
- Analyst Count
- GMS 8
- PCVX 8
- Target Price
- GMS $105.71
- PCVX $135.00
- AVG Volume (30 Days)
- GMS 898.4K
- PCVX 1.4M
- Earning Date
- GMS 08-28-2025
- PCVX 11-04-2025
- Dividend Yield
- GMS N/A
- PCVX N/A
- EPS Growth
- GMS N/A
- PCVX N/A
- EPS
- GMS 2.61
- PCVX N/A
- Revenue
- GMS $5,479,614,000.00
- PCVX N/A
- Revenue This Year
- GMS $0.39
- PCVX N/A
- Revenue Next Year
- GMS $4.99
- PCVX N/A
- P/E Ratio
- GMS $42.21
- PCVX N/A
- Revenue Growth
- GMS N/A
- PCVX N/A
- 52 Week Low
- GMS $65.77
- PCVX $27.66
- 52 Week High
- GMS $110.28
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- GMS 1.29
- PCVX 50.16
- Support Level
- GMS $109.82
- PCVX $31.47
- Resistance Level
- GMS $109.99
- PCVX $33.32
- Average True Range (ATR)
- GMS 0.03
- PCVX 1.27
- MACD
- GMS -13.57
- PCVX 0.24
- Stochastic Oscillator
- GMS 0.00
- PCVX 62.89
About GMS GMS Inc.
GMS Inc is a distributor of specialty building products including wallboard, suspended ceiling systems, ceilings, steel framing, and other complementary building products. The company serves its products to commercial new construction, commercial repair and remodel, residential new construction, and residential repair and remodel (R&R). Its geographical segment is Central, Midwest, New York, Northeast, Southern, Southeast, Southwest, Western and Canada. The company generates maximum revenue from Wallboard products.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.